Nuzenio

Mantle Cell Lymphoma

Mantle Cell Lymphoma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Sonrotoclax Is Active in Chinese R/R MCL Cohort of the BGB-11417-201 Trial - OncLiveOncLive · Sat, 08 Aug 2026 10:13:24 GMT Hundreds to benefit from new treatment option for mantle cell lymphoma and chronic lymphocytic leukaemia - wired-gov.netwired-gov.net · Thu, 06 Aug 2026 16:17:41 GMT NICE Expands First-Line Options for Two Blood Cancers - MedscapeMedscape · Thu, 06 Aug 2026 11:51:08 GMT NICE recommends new treatment for Mantle Cell Lymphoma and Chronic Lymphocytic Leukaemia - National Health ExecutiveNational Health Executive · Thu, 06 Aug 2026 09:32:12 GMT Comparing CV Safety and Exploratory Bleeding Outcomes of BTK Inhibitors in Mantle Cell Lymphoma - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Wed, 05 Aug 2026 20:44:48 GMT Combining BTK and BCL2 Inhibitors in Mantle Cell Lymphoma: Eyre Weighs in on Where the Field Goes Next - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Tue, 04 Aug 2026 13:00:00 GMT Autologous Transplant in Mantle Cell Lymphoma: Declining Use Leads to Improved Patient Tolerability and New Alternatives Emerge - ASCO Daily NewsASCO Daily News · Thu, 30 Jul 2026 22:33:11 GMT

Timeline

Sat, 08 Aug 2026 10:13:24 GMTSonrotoclax Is Active in Chinese R/R MCL Cohort of the BGB-11417-201 Trial - OncLive

Thu, 06 Aug 2026 16:17:41 GMTHundreds to benefit from new treatment option for mantle cell lymphoma and chronic lymphocytic leukaemia - wired-gov.net

Thu, 06 Aug 2026 11:51:08 GMTNICE Expands First-Line Options for Two Blood Cancers - Medscape

Thu, 06 Aug 2026 09:32:12 GMTNICE recommends new treatment for Mantle Cell Lymphoma and Chronic Lymphocytic Leukaemia - National Health Executive

Wed, 05 Aug 2026 20:44:48 GMTComparing CV Safety and Exploratory Bleeding Outcomes of BTK Inhibitors in Mantle Cell Lymphoma - The American Journal of Managed Care® (AJMC®)

Tue, 04 Aug 2026 13:00:00 GMTCombining BTK and BCL2 Inhibitors in Mantle Cell Lymphoma: Eyre Weighs in on Where the Field Goes Next - The American Journal of Managed Care® (AJMC®)

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

The American Journal6 live mentions Managed Care6 live mentions AJMC6 live mentions National Health Executive3 live mentions ASCO Daily News3 live mentions Chinese R2 live mentions R MCL Cohort2 live mentions BGB2 live mentions Hundreds2 live mentions Line Options2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Mantle Cell Lymphoma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.